Drug Shortage Report for OPTIMYXIN
Report ID | 124877 |
Drug Identification Number | 00701785 |
Brand name | OPTIMYXIN |
Common or Proper name | Gramicidin and Polymyxin B Sulfate Oto-Ophthalmic Solution |
Company Name | EURO-PHARM INTERNATIONAL CANADA INC |
Market Status | MARKETED |
Active Ingredient(s) | GRAMICIDIN POLYMYXIN B |
Strength(s) | 0.025MG 10000UNIT |
Dosage form(s) | DROPS |
Route of administration | OPHTHALMIC OTIC OPHTHALMIC OTIC |
Packaging size | 10 mL |
ATC code | S03AA |
ATC description | ANTIINFECTIVES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-11-01 |
Actual start date | |
Estimated end date | 2025-07-01 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-02-06 |
Company comments | Reason for shortage: Transfer of manufacturing site. The estimated end date depends on approval timelines for the manufacturing site transfer. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9400 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information | Ali Khamessan |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-09-24 | English | Compare |
v2 | 2020-09-24 | English | Compare |
v3 | 2020-09-24 | French | Compare |
v4 | 2020-09-24 | French | Compare |
v5 | 2020-11-02 | English | Compare |
v6 | 2022-01-17 | English | Compare |
v7 | 2024-02-06 | English | Compare |
v8 | 2024-02-06 | French | Compare |
v9 | 2024-02-06 | English | Compare |
v10 | 2024-02-06 | French | Compare |
Showing 1 to 10 of 10